Cancer

Combination immunotherapy targets cancer resistance

Cancer immunotherapy drugs have had notable but limited success because in many cases, tumors develop resistance to treatment. But researchers at Yale and Stanford have identified an experimental antibody that overcomes this ...

Cancer

Cell-weighing method could help doctors choose cancer drugs

Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Cancer

Chemist has designs on drug-resistant breast cancer

Dr. Jung-Mo Ahn, associate professor of chemistry and biochemistry at The University of Texas at Dallas, has designed a small molecule that could help breast cancer patients for whom current treatments no longer work.

Immunology

Novel approach could limit common complications of immunotherapy

By connecting highly effective cancer immunotherapy drugs such as anti-CTLA4 (ipilimumab) and anti-PD-L1 (atezolizumab) to peptides that bind to tissues in and around tumors, a research team based at the University of Chicago ...

Cancer

Cancer research – how a traffic jam causes tumor growth

For tissues to cooperate and perform normal functions, cells need to know which way is up. When cells lose track of their orientation, they can start to grow out of control, and develop into cancer. Now, a team of researchers ...

page 10 from 23